logo
Surgeons use new technique to save life of little boy with rare condition

Surgeons use new technique to save life of little boy with rare condition

Independent6 days ago
Surgeons have used a new technique to save the life of a toddler who was born with an extremely rare birth defect in what is thought to be a world first.
Conor O'Rourke, now three, was diagnosed with vein of galen malformation (VOGM) as a baby after a doctor raised concerns about the size of his head at an appointment for an unrelated issue.
The condition causes the veins and arteries in the brain to connect abnormally, increasing blood flow and leading to severe complications such as heart failure and brain damage, and death if undetected.
The toddler from Bolton is one of a rare subgroup of patients with VOGM which left him essentially untreatable.
Specialists at Alder Hey Children's Hospital in Liverpool performed the novel technique, which involved open surgery deemed 'high risk', in March.
Conor, who has since recovered well, would have deteriorated neurologically over a year or two without the operation, according to specialists.
His surgeon told the PA news agency the boy is now considered '99% cured' and has become a 'different child'.
Conor was around eight or nine months old when his mum Lucy O'Rourke, 36, took him to an appointment with a consultant over an issue with his belly button.
However, while there, the doctor raised concerns about the size of her baby's head.
Conor was eventually diagnosed with VOGM in March 2023, which his mum said was 'terrifying'.
The condition causes arteries to connect directly to the vein of galen – a deep vein in the brain that drains blood from the brain back to the heart – rather than connecting to capillaries, which would slow down blood flow.
It affects roughly 10 to 12 babies in the UK every year.
Mrs O'Rourke told PA: 'I genuinely felt like I was living in a nightmare, and I felt like there was going to be a point where somebody was going to phone me and say, 'sorry, we've mixed up the scans, this isn't your child, we've got it wrong', and we just felt completely helpless in that moment in time.
'We just cried and sat in silence for hours. We just didn't know what to do with ourselves.'
The treatment for VOGM involves inserting a small, flexible tube called a catheter into the arteries, usually from the groin.
Medics use X-ray imaging to guide the tube through the body and into place, and then inject a glue-like substance to block off the artery.
In some cases, the same procedure can be performed by inserting the catheter into the veins.
Conor had three of these operations in 2023.
Conor Mallucci, a consultant paediatric neurosurgeon at Alder Hey, told PA: 'Conor had already had those procedures, both from the artery and the vein, but after a while, in a rare subgroup of these patients, the veins block off and you can no longer get to the malformation.
'And you can't get up there through the artery either, and so you're left with an untreatable malformation that's still supplying abnormal blood to the veins.'
When this happens, the jugular veins – a set of major blood vessels in the neck – block off.
'That's rare to this condition, but it's specific to this condition,' Mr Mallucci said.
'And when the jugular veins block off, which happened in Conor, the veins from the brain try and drain elsewhere.
'In his case, he had all these abnormal channels draining to his brain stem and spinal cord. And that results in swelling and damage, which is why he was deteriorating over time.'
Mrs O'Rourke told PA her son suffered a small stroke after his third operation in November 2023.
Around a year later, and after physiotherapy, the toddler's family were told he was not in a position for more operations and they would scan him in 12 months' time.
While his parents were initially 'so happy' to have a year with no scans, they soon noticed their son was struggling.
Mrs O'Rourke said: 'In early December, I started to notice that physically he was struggling, and he was limping quite a bit on his left leg.'
Mr Mallucci said, by this point, Conor was essentially 'untreatable' and had 'run out of all his options'.
'It's a fight against time, and that happened quite early in Conor, which is why we had to come up with this alternative route,' he added.
'You couldn't get into his head through the veins, because the jugular veins have blocked off, and you can't block off through the artery any more.
'So that's when we came up with our technique, which is to access the veins through open surgery beyond the blockage.'
The operation involved accessing the malformation through the skull to target the affected blood vessels.
Alder Hey is one of only two centres in the UK equipped to carry out this procedure on children.
The hospital has a state-of-the-art theatre with advanced imaging machinery, giving specialists real-time X-ray pictures of blood vessels during operations and allowing them to combine endovascular and open surgery.
The technique has never been performed at another hospital.
Mr Mallucci told PA: 'Exposing these veins that were blocked at the jugular level is high risk.
'You lose blood. It's a big operation, and to put a needle directly into one of those is a little bit hair raising, so we had to be very careful about that.'
Medics told Mrs O'Rourke her son would very tired after surgery and was expected to sleep for around a week and remain in hospital for up to six weeks.
However, Conor woke up soon after the operation asking for chips and the family were home after 10 days.
Mrs O'Rourke said: 'I obviously went into mum mode and said 'can we get some chips in here please?'
Speaking of Conor's recovery, Mr Mallucci said: 'He's not only recovered well, everything that he had going bad was reversed.
'He's become a different child, really, it's like he's suddenly been released.'
Mr Mallucci told PA Conor is considered '99% cured' and will not need any more operations.
Instead, he will have annual scans to monitor his brain and potentially have an angiogram – when a dye is injected into the bloodstream to allow doctors to capture images of blood vessels using X-ray – in around four to five years.
Mrs O'Rourke said: 'No surgery now – unless we get broken arms or legs – but with something like that, we're kind of like 'bring it on'.
'As long as it's not more brain surgery, then we'll probably be able to cope with that.'
Specialists at Alder Hey have performed the new technique on two patients, including Conor, and have a third lined up.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Officials urge caution on mosquito bites abroad amid rise in chikungunya cases
Officials urge caution on mosquito bites abroad amid rise in chikungunya cases

The Independent

timean hour ago

  • The Independent

Officials urge caution on mosquito bites abroad amid rise in chikungunya cases

Health officials have urged people to take precautions against mosquito bites while on holiday amid a rise in cases of chikungunya among travellers returning from abroad. The UK Health Security Agency (UKHSA) has also detected the first cases of the emerging disease oropouche virus in the UK, all of which were linked to travel from Brazil. Chikungunya is a virus spread by mosquito bites, the symptoms of which include a sudden fever and joint pain. According to UKHSA, most people recover within two weeks, although the joint pain can last for months or even years in some cases. Serious complications are not common, but in rare cases the disease can be fatal, particularly in very young or older people, or those with underlying health conditions. The latest travel-associated infections report from UKHSA shows there were 73 cases of chikungunya reported between January and June 2025, compared to 27 cases for the same period last year. The majority were linked to travel to Sri Lanka, India and Mauritius. All cases were reported in England, primarily in London. There is currently no risk of onward transmission of chikungunya, as the two species of mosquito that transmit the disease are not established in the UK, UKHSA said. The illness mainly occurs in Africa and Asia, specifically southern Asia, although cases have been reported in Europe and parts of North America. However, this year there have been outbreaks in the Americas and Asia, with surges in China and the Indian Ocean islands of Reunion, Mayotte and Mauritius. Dr Philip Veal, consultant in public health at UKHSA, said: 'Chikungunya can be a nasty disease and we're seeing a worrying increase in cases among travellers returning to the UK. 'While this mosquito-borne infection is rarely fatal, it can cause severe joint and muscle pain, headaches, sensitivity to light and skin rashes. Thankfully symptoms usually improve within a few weeks, but joint pain may last for months or longer. 'It is essential to take precautions against mosquito bites when travelling. 'Simple steps, such as using insect repellent, covering up your skin and sleeping under insecticide-treated bed nets can greatly reduce the risk.' Two chikungunya vaccines are approved for use in the UK and are available to buy after an assessment at a private travel clinic. Meanwhile, the first UK cases of oropouche virus, which is spread by midge bites, have been detected by UKHSA. The three cases were all associated with travel to Brazil. The flu-like illness can cause a fever, headaches, joint pain, muscle pain, chills, nausea and vomiting. Officials urged anyone who becomes unwell with these symptoms after travel to affected areas, including parts of Central and South America and the Caribbean, to seek urgent medical advice. According to the World Health Organisation (WHO), before late 2023, oropouche virus was mostly reported near the Amazon rainforest area. However, in 2024, Brazil, Bolivia, Colombia, Cuba, Guyana, Peru and the Dominican Republic reported locally transmitted cases of the disease. The UKHSA report also shows a rise in travel-associated cholera cases in the UK, with eight cases in the first half of the year compared to just one in 2024. Most cases were linked with travel to India and Ethiopia. There was also a 67% decrease in the number of dengue cases reported in England, Wales and Northern Ireland from January to June, and there were just four cases of zika virus during the period, down from nine in 2024.

ADHD drugs have wider life benefits, study suggests
ADHD drugs have wider life benefits, study suggests

BBC News

timean hour ago

  • BBC News

ADHD drugs have wider life benefits, study suggests

Drug treatment can help people newly diagnosed with ADHD (attention deficit hyperactivity disorder) to reduce their risk of substance misuse, suicidal behaviour, transport accidents and criminality, a study issues are linked to common ADHD symptoms such as acting impulsively and becoming easily 5% of children and 2.5% of adults worldwide are thought to be affected by the disorder - and growing numbers are being findings, published in the British Medical Journal (BMJ), confirm the wider potential benefits of drug treatment and could help patients decide whether to start medication, the researchers say. Having ADHD means the brain works differently to most other people's. Symptoms can include difficulties concentrating and sitting still, having high energy levels and being impulsive. Despite the surge in people asking for help, the disorder is not becoming more common. Last year a BBC investigation found long waits for assessment in the are only diagnosed if the symptoms cause at least a moderate impact on their lives. The most commonly prescribed drugs, called stimulants, help manage everyday symptoms but there has been limited evidence of longer-term benefits for people's behaviour, while well-publicised side-effects, such as headaches, loss of appetite and trouble sleeping, have sparked debate on their safety. This BMJ study was based on 148,500 people aged six to 64, with ADHD in Sweden. Some 57% started drug treatment and, of these, methylphenidate (also known as Ritalin), was prescribed, to 88%.The researchers, from Southampton University and the Karolinska Institute in Stockholm, found taking ADHD medication was linked to reductions of first-time instances of: suicidal behaviour - 17%substance misuse - 15%transport accidents - 12%criminal behaviour - 13%When recurrent events were analysed, the researchers found ADHD medication was linked to reductions of: 15% for suicide attempts25% for substance misuses4% for accidental injuries16% for transport accidents25% for criminal behaviour "Oftentimes there is no information on what the risks are if you don't treat ADHD," said Prof Samuele Cortese, study author and professor of child and adolescent psychiatry at University of Southampton."Now we have evidence they [drugs] can reduce these risks."This could be explained by medication reducing impulsive behaviour and lack of concentration, which might reduce the risk of accidents while driving and reduce aggressive behaviour which could lead to researchers say the study was designed to be as robust as possible but cannot rule out the possibility the results were affected by factors such as people's genes, lifestyles and the severity of their ADHD. Accessing the right medication for ADHD in many countries is not easy, with some drugs in short supply. In the UK waiting times to see specialists after diagnosis in order to access drugs can be several Stuart Kinner, head of the Justice Health Group at Curtin University in Western Australia, said the research demonstrated "the diffuse benefits of ADHD diagnosis and treatment". "Failure to diagnose and treat ADHD can lead to self-medication with alcohol or other drugs, poor mental health, injury, and incarceration," he said. "Too many people with undiagnosed ADHD end up in the criminal justice system, where their condition may remain undiagnosed and untreated."Ian Maidment, professor in clinical pharmacy at Aston University, said the study "adds to our understanding of the potential benefits of these drugs".However, he said the research did not assess whether patients actually took their medication or the impact of different doses.

Cases of killer virus that makes the body ‘fold in on itself' soaring in UK – after virus sparks pandemic fears in China
Cases of killer virus that makes the body ‘fold in on itself' soaring in UK – after virus sparks pandemic fears in China

The Sun

timean hour ago

  • The Sun

Cases of killer virus that makes the body ‘fold in on itself' soaring in UK – after virus sparks pandemic fears in China

CASES of a killer virus that can make the body 'fold in on itself' have increased in the UK, health chiefs have warned. There were 73 cases of chikungunya, a mosquito-borne disease that causes crippling joint pain, between January and June 2025 in England, Wales and Northern Ireland - the highest number ever recorded. 5 This is over double the 27 cases reported during the same period in 2024, UK Health Security Agency (UKHSA) data from its most recent travel-associated infection report suggests. The first cases of the oropouche have also been reported in the UK, which were all linked to travel from Brazil. The oropouche virus, dubbed ' sloth fever ', circulates between primates, sloths, and birds in the wild - before it is occasionally passed to humans by midges and mosquitoes. It is primarily found in the Amazon basin in South America, but in recent years has started spreading more widely around the Americas. Health officials have since urged people to take precautions against insect bites while on holiday, as cases of both infections surge. Chikungunya spreads through the bite of infected Aedes mosquitoes, particularly Aedes aegypti and Aedes albopictus species. The virus is rarely deadly, but can cause serious disease spread by the in the very young, older people and those with other underlying illnesses. Typical symptoms include: Excruciating joint pain, which can leave victims hunched or folded over in agony High fever Headache Muscle aches Nausea Fatigue Red, bumpy rash Swelling in the joints, particularly the hands and feet In severe cases, the joint pain can mimic arthritis, leaving sufferers temporarily disabled for months or even years. Oropouche virus The illness mainly occurs in Africa and Asia, specifically southern Asia, although cases have been reported in Europe and parts of North America. However, this year there have been outbreaks in the Americas and Asia, with surges in China and the Indian Ocean islands of Reunion, Mayotte and Mauritius. The majority of UK cases reported this year were linked to travel to Sri Lanka, India and Mauritius. All cases were reported in England, primarily in London. There is currently no risk of onward transmission of chikungunya, as the two species of mosquito that transmit the disease are not established in the UK, UKHSA said. Meanwhile, more than 7,000 people have been struck down by the virus in China since June 2025, according to national health officials. 5 5 The majority of cases have been reported in Foshan, a city in southern Guangdong province, where officials have since rolled out Covid-style lockdowns in a desperate bid to stop the virus from spiralling out of control. At least 12 other cities in the southern Guangdong province have also reported infections. Hong Kong and Taiwan have also reported cases. Dr Philip Veal, consultant in public health at UKHSA, said: "Chikungunya can be a nasty disease and we're seeing a worrying increase in cases among travellers returning to the UK. "While this mosquito-borne infection is rarely fatal, it can cause severe joint and muscle pain, headaches, sensitivity to light and skin rashes. "Thankfully, symptoms usually improve within a few weeks, but joint pain may last for months or longer." He added: "It is essential to take precautions against mosquito bites when travelling. "Simple steps, such as using insect repellent, covering up your skin and sleeping under insecticide-treated bed nets can greatly reduce the risk." Two chikungunya vaccines are approved for use in the UK and are available to buy after an assessment at a private travel clinic. Meanwhile, three cases of oropouche virus have been detected by UKHSA. How concerning is this outbreak in China? Though tactics adopted by authorities in China hark back to lockdown measures five years ago, chikungunya "does not pose the same level of pandemic threat as a virus like Covid-19", according to Prof Tom Solomon, director of The Pandemic Institute in Liverpool. Dr César López-Camacho, from the Jenner Institute at the University of Oxford, added: 'It is extremely unlikely to cause a pandemic in the traditional sense, as chikungunya does not spread from person to person. "However, it can cause large regional outbreaks, especially when introduced to mosquito-rich, low-immunity settings, like what we are probably seeing in China." The risk to the UK from this outbreak is "currently low" as Aedes mosquitoes, which tend to carry the virus, aren't widespread here. "But we do need to watch closely, as climate change and global travel are expanding the range of these mosquitoes, and with it, the viruses they carry," Dr López-Camacho warned. 'It is also important that genetic sequencing of the virus in this outbreak is carried out. "In past outbreaks, mutations have helped chikungunya adapt to new mosquito species. "If the virus has changed, we need to ensure current vaccines still offer protection." Brits travelling to China amidst the outbreak should "be cautious", the disease expert said. He continued: "The US Centre for Disease Control and Prevention has issued a Level 2 travel alert, recommending travellers use insect repellent, wear long sleeves, and stay in screened or air-conditioned accommodation. "Travellers returning from affected areas who develop fever and joint pain should seek medical attention and mention their recent travel." People travelling to high-risk areas where outbreaks of the virus often occur can get vaccinated against chikungunya at a travel clinic. But Prof Solomon noted: "There have been reports of serious side effects in people over the age of 65. "As such, the vaccine is currently recommended for travellers under 65 visiting high-risk areas." The flu-like illness can cause a fever, headaches, joint pain, muscle pain, chills, nausea and vomiting. Officials urged anyone who becomes unwell with these symptoms after travel to affected areas, including parts of Central and South America and the Caribbean, to seek urgent medical advice. According to the World Health Organisation (WHO), before late 2023, oropouche virus was mostly reported near the Amazon rainforest area. However, in 2024, Brazil, Bolivia, Colombia, Cuba, Guyana, Peru and the Dominican Republic reported locally transmitted cases of the disease. The UKHSA report also shows a rise in travel-associated cholera cases in the UK, with eight cases in the first half of the year compared to just one in 2024. Most cases were linked with travel to India and Ethiopia. There was also a 67 per cent decrease in the number of dengue cases reported in England, Wales and Northern Ireland from January to June. And there were just four cases of zika virus during the period, down from nine in 2024. 5 Oropouche virus: Everything you need to know Oropouche fever is a disease caused by Oropouche virus It is spread through the bites of infected midges (small flies) and mosquitoes. Symptoms of Oropouche fever are similar to dengue and include headache, fever, muscle aches, stiff joints, nausea, vomiting, chills, or sensitivity to light. Severe cases may result in brain diseases such as meningitis. Symptoms typically start 4–8 days after being bitten and last 3–6 days. Most people recover without long-term effects. There are no specific medications or vaccines are available. Precautions Travellers heading to affected areas should take steps to avoid bug bites. The virus is endemic in many South American countries, in both rural and urban communities. Outbreaks are periodically reported in Brazil, Bolivia, Colombia, Ecuador, French Guiana, Panama, Peru, and Trinidad and Tobago. Wear tops with long sleeves and long trousers, apply insect repellent regularly, and sleep under a mosquito net if you are not in enclosed, air-conditioned accommodation. Source: US Centre for Disease Control and Prevention

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store